π¬ CNS tumor care: molecular testing gaps in Saudi Arabia
A survey assessed molecular neuropathology practices in Central Nervous System tumor care across Saudi Arabia. The study involved 131 healthcare professionals surveyed from February 12 to May 31, 2026. Only 13.0% reported having molecular neuropathologists, while 95.8% felt precision medicine was relevant. Despite this, only 16.7% reported actually implementing precision medicine in care. Respondents strongly urged for more research and better referral systems. π¬